NL-OMON43723
Completed
Not Applicable
Proteomics analysis of cerebrospinal fluid to investigate brain involvement in pre-eclampsia - LEPRA II (liquor cerebrospinalis and pre-eclampsia)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- neurologische aandoeningen tijdens de zwangerschap
- Sponsor
- Erasmus MC, Universitair Medisch Centrum Rotterdam
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Non pregnant women of 18 year and older
Exclusion Criteria
- •Pregnant during inclusion
- •Pre\-eclampsia in history
- •Auto\-immune disorders
- •Oral corticosteroid use
- •Hemoglobinopathy or clotting disorder
- •Chronic hypertension or proteinuria
- •Kidney disorders
- •Neurologic disorder
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Proteomics analysis of cerebrospinal fluid for screening of POCD-associated moleculesThoracic aortic aneurysmJPRN-UMIN000035805Mie University20
Recruiting
Not Applicable
Proteomics of cerebrospinal fluid after remote ischemic preconditioninganeurysm of the thoracic aortaJPRN-UMIN000034214Mie university hospital30
Completed
Not Applicable
Plasma and cerebrospinal fluid concentrations treated with daily dose and high dose weekly erlotinib in non-small cell lung cancer patients with central nervous system metastasescentral nervous system metastases of non-small cell lung cancer with active EGFR mutations treated with daily dosing erlotinibJPRN-UMIN000004703Osaka City University10
Completed
Not Applicable
An investigation on spinal fluid in patients with sciatica-type or nerve-type pain of the lower limbeuropathic lower limb painNervous System DiseasesISRCTN34007592Trinity Translational Medicine Institute12
Active, not recruiting
Not Applicable
Cerebrospinal fluid (CSF) and plasma pharmocokinetics of liposomal cytarabine (DepoCyte®) after intrathecal administration in children with malignant brain tumors and leptomeningeal disseminatioTo measure concentrations of liposomal cytarabine in CSF and plasma over time after intrathecal administration of liposomal cytarabine in children of different age groups with a malignant brain tumor and leptomenigeal dissemination. Measurements of concentrations of cytarabine after intrathecal administration of liposomal cytarabine will help to ensure proper dosage of liposomal cytarabine in small children, avoiding neurotoxic events and subtherapeutic drug levels.EUCTR2006-004982-32-ATMedical University of Vienna, Department of Pedatrics